Cara therapeutics stock price today

Dec 18, 2019 · Cara Therapeutics recently reported the top-line results of its phase II clinical study of oral KORSUVA in patients with CKD-associated pruritus.Following the positive phase II clinical trial CARA Stock News - Fidelity Apr 03, 2020 · Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the Compensation Committee of Cara s Board of Directors has approved the grant of non-qualified stock options How Does the Market View Cara Therapeutics Inc (CARA ...

Cara Therapeutics (NasdaqGM:CARA) - Share price, News ...

About Cara Therapeutics Inc CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. CARA | Cara Therapeutics Inc. Stock Price & News - WSJ Cara Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CARA stock price. Dow Jones, a News Corp company. Cara Therapeutics Stock Quote: CARA Stock News, Quotes ...

Jan 01, 2010 · Cara Therapeutics (NASDAQ: CARA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on

Stock quote for Cara Therapeutics, Inc. Common Stock Common Stock (CARA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. CARA Therapeutics Inc. - NASDAQ:CARA - Stock Quote & News ...